REDWOOD CITY, CA -- (Marketwire) -- 02/11/10 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that it will release its financial results for the full year and fourth quarter 2009 following the close of the U.S. financial markets on Tuesday, February 23, 2010. Following the release, Facet will hold a conference call ... read more

REDWOOD CITY, CA -- (Marketwire) -- 02/02/10 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that the company will participate at the 2010 BIO CEO & Investor Conference in New York on Tuesday, February 9, 2010 at 8:30 a.m., Eastern Time. The conference is hosted by the Biotechnology Industry Organization (BIO) and ... read more

REDWOOD CITY, CA -- (Marketwire) -- 12/16/09 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that in response to a request from The Baupost Group, L.L.C., the Company has agreed to amend its Rights Agreement to permit Baupost to purchase a number of additional shares without the rights under the Rights Agreement becoming ... read more

REDWOOD CITY, CA -- (Marketwire) -- 12/15/09 -- The board of directors of Facet Biotech Corporation (NASDAQ: FACT) today reiterated its recommendation that stockholders not tender their shares into, and reject the unsolicited, revised conditional tender offer from Biogen Idec Inc. (NASDAQ: BIIB) to acquire all of the outstanding shares of Facet Biotech ... read more

REDWOOD CITY, CA -- (Marketwire) -- 08/03/09 -- Facet Biotech Corporation (NASDAQ: FACT) today announced its decision, along with its partner Biogen Idec, to continue planning for the phase 3 trial of daclizumab high-yield process (DAC HYP) in multiple sclerosis (MS). The company plans to request a Special Protocol Assessment from the ... read more

REDWOOD CITY, CA -- (Marketwire) -- 04/27/09 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that it will release its financial results for the first quarter 2009 following the close of the U.S. financial markets on Tuesday, May 5, 2009. Following the release, Facet will hold a conference call at 4:30 p.m. ... read more

REDWOOD CITY, CA -- (Marketwire) -- 03/31/09 -- Facet Biotech Corporation (NASDAQ: FACT) announced today that it has received a notice of intention to nominate five candidates for election to Facet Biotech's five-person Board of Directors at its 2009 Annual Meeting of Stockholders. Sent by Roderick Wong, the notice states the intent ... read more

REDWOOD CITY, CA -- (Marketwire) -- 03/16/09 -- Facet Biotech Corporation (NASDAQ: FACT) today provided 2009 financial guidance and reported financial results for the fourth quarter and full year ended December 31, 2008. On December 18, 2008, Facet Biotech completed its spin-off from PDL BioPharma, Inc. (PDL). PDL capitalized Facet with $405 ... read more

REDWOOD CITY, CA -- (Marketwire) -- 03/09/09 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that it will release its financial results for the fourth quarter and full year 2008 following the close of the U.S. financial markets on Monday, March 16, 2009. Following the release, Facet will hold a conference call ... read more

REDWOOD CITY, CA -- (Marketwire) -- 02/24/09 -- Facet Biotech Corporation (NASDAQ: FACT) today announced the election of Kurt von Emster as a member of its board of directors. "We are pleased to welcome Kurt, a biotechnology veteran, to Facet's board," said Brad Goodwin, chairperson of Facet Biotech's board of directors. "Kurt's thorough understanding ... read more